Keywords: India, Fake drugs, Whistleblower rewards, API market

India to reward whistleblowers to help fight spurious/fake drugs problems

Article | 18 August 2010

India’s Ministry of Health and Family Welfare has acknowledged that spurious or fake drugs are sensitive issues affecting the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in